ÂÜÀòÂÒÂ×

Heng-wen (Alison) Liu, PhD, is a Senior Manager in Portfolio Strategy & Analytics at Gilead Sciences since August 2021, where responsibilities include decision quality analysis and cross-functional team facilitation for risk assessments and strategic insights. Prior experience includes contributions at Genentech in portfolio strategy during a pivotal period of COVID-19, participation in a McKinsey insight program, and extensive project management during doctoral studies at The Johns Hopkins University, recognized by multiple awards and patents in nanomedicine and cancer gene therapy. Educational background features a PhD in Materials Science and Engineering from The Johns Hopkins University, a Master's degree from National Chiao Tung University, and a Bachelor's degree in the same field. Additional roles include technical support at KLA-Tencor and various teaching assistantships, enhancing both technical expertise and communication skills in scientific contexts.